Please ensure Javascript is enabled for purposes of website accessibility
Issues
Markets, led by Nasdaq’s leading companies, had an impressive winning streak broken by concerns over an acceleration of coronavirus cases. Our Emerging Markets signal (EEM) stays positive as the virus is being handled well in Asia outside of China but is exploding in Latin America. The Explorer portfolio is well positioned with cash to deploy and stocks holding up well.

Today, we’ll look inside the indexes to see what’s working and also explore what more participation by individual investors in 2020 might mean for markets. Then we move north to Canada for a promising new recommendation that has all the characteristics of a winning gold stock.


This is a fantastic environment for income. The upward bias of the market is creating high call premiums. And certain pockets of the market still offer deep value and higher dividend yields than have existed in many years.

In this issue I identify three excellent dividend stocks to buy now.



One is a high yielding energy play with a stratospheric, but safe, yield. Another is one of the most defensive and reliable income generating stocks in the market that still offers good value and a strong yield. And the third is a technology stock that sells at a reasonable price with an incredibly strong catalyst for the stock price to shoot up in the future.



The issue also includes covered calls on these same stocks that will provide a double digit income in a short time if the stocks move higher, and a great income return if they don’t.


After eleven weeks up, the broad market has been correctingfor the past fethreew weeks, and the marijuana stocks are also in gear, totally synchronized—which is good. Bottom line, this correction provides a fine buying opportunity.

I’m taking advantage of this opportunity to average up in Canada’s leading producer, Aphria (APHA). And I’m sticking with all the other portfolio stocks because I truly think we have a portfolio that will thrive as this industry matures.



Full details in the issue.

In what came as a shock to many, some brick-and-mortar retailers actually did quite well during the shutdown. This retailer emerged as one of the winners in the locked down economy, keeping all its stores open during the pandemic and reporting strong online business (+45%) and higher comparable store sales in April.
Market Gauge is 8Current Market Outlook


After three weeks of rotation, where cyclical stocks took the reins and growth stocks rested (and some broad selling pressure showed up June 11-12), the reverse occurred last week, with the leaders again ramping up and cyclical stocks sagging. Still, while the endless rotation isn’t ideal, it hasn’t changed the big picture—most of the evidence remains bullish, so we’re still optimistic the path of least resistance is higher. That said, it’s important to keep your feet on the ground, too; looking for solid entry points and not hesitating to book some partial profits on the way up are still good ideas, as some selling pressure or another bout of rotation isn’t out of the question. We’re leaving our Market Monitor at a level 8.

This week’s list has a bit of a secondary feel to it, but many are showing solid setups; ideally some of these will be the next wave of names big investors focus on. Our Top Pick is Restoration Hardware (RH), which has a strong story and is resting nicely after a very strong run.
Stock NamePriceBuy RangeLoss Limit
Big Lots (BIG) 43.1232.5-3527.5-28.5
Immunomedics (IMMU) 34.2332.5-3528-29
LGI Homes (LGIH) 86.0484-8774-75.5
MercadoLibre, Inc. (MELI) 980.83910-940810-830
Mersana Therapeutics (MRSN) 22.2820-2216-17.5
Nuance Communications, Inc. (NUAN) 25.3523.5-2521-22
PagSeguro Digital (PAGS) 35.0933.5-35.529-30
RH Inc. (RH) 252.93240-255210-217
Teradyne (TER) 82.8378-8169-71
Yeti Holdings (YETI) 42.8036-3831.5-33

The market remains in good health, so I continue to recommend that you be heavily invested in a diversified portfolio of the best stocks, both strong momentum stocks (we have several) and lower-risk dividend-paying slower growers. In the portfolio this week, the only change is an upgrade of Vertex Pharmaceuticals (VRTX) to buy.

As for the newest recommendation, it’s unusual in that it’s not one stock; it’s actually an ETF of a market sector that I think holds spectacular promise in the long term.


Get this Investor Briefing now, How to Pick the Best Stocks from Around the World, and you’ll learn how global investing can be a profitable strategy for you. From understanding global investing to the six key rules to follow about global investing … from how to invest for the future to robotics stocks you should consider … and from everything you should know about fintech investing to the best Canadian stocks to buy now. How to Pick the Best Stocks from Around the World is your best guide to a making a global investing strategy work for you.
Markets rebounded this past month, albeit with plenty of volatility. But the net result was a 1,500+ gain in the Dow Jones Industrial Markets.

Unemployment, of course, is still pressuring the economy, with some 29.5 million Americans without jobs. However, the housing market perked up, with starts and building permits rising. Retail sales—reflecting the reopening of the economy—were also up.

It’s worrying that coronavirus is rising in about 20 states, but, hopefully, if people begin once again following social distancing, the new cases won’t push us off the economic reopening strategy.

Advisors and consumers are back on the bullish track, as you’ll see in our Barometer, as well as Market Views.

Despite the market’s rise, there are still plenty of undervalued stocks in the marketplace. And we begin this issue with our Spotlight Stock, a technology company that is gaining market share in the highly competitive field of cybersecurity—in this case, specializing in ID authentication for employees and customers. My feature article explores the industry in more depth, as well as additional reasons for adding our Spotlight Stock to your portfolio.
There remain some yellow flags in the market, but when you look at the big picture, there remains far more good than bad. It’s vital to remain flexible of course, as in 2020, things have changed on a dime a couple of times, but with most of the evidence still positive, we remain mostly bullish.
Markets rebounded this past month, albeit with plenty of volatility. But the net result was a 1,500+ gain in the Dow Jones Industrial Markets.

Unemployment, of course, is still pressuring the economy, with some 29.5 million Americans without jobs. However, the housing market perked up, with starts and building permits rising. Retail sales—reflecting the reopening of the economy—were also up.



It’s worrying that coronavirus is rising in about 20 states, but, hopefully, if people begin once again following social distancing, the new cases won’t push us off the economic reopening strategy.



Advisors and consumers are back on the bullish track, as you’ll see in our Barometer, as well as Market Views.



Despite the market’s rise, there are still plenty of undervalued stocks in the marketplace. And we begin this issue with our Spotlight Stock, a technology company that is gaining market share in the highly competitive field of cybersecurity—in this case, specializing in ID authentication for employees and customers. My feature article explores the industry in more depth, as well as additional reasons for adding our Spotlight Stock to your portfolio.

Updates
Thirteen Cabot Benjamin Graham Value Investor companies reported quarterly financial results or other noteworthy news. Included in my summaries are three new sell recommendations: BJ’s Restaurants (BJRI), W.W. Grainger (GWW) and iShares Minimum Volatility USA ETF (USMV).
Not much has changed with the market during the past week, so we’re sticking with our stance—the Model Portfolio has 40% in cash and holding six resilient stocks. We continue to believe the next major market move is up, but in the near-term, you should take your cues from the market and individual stocks. We have no changes tonight.
Two of our stocks—Reynolds American (RAI) and U.S. Bancorp (USB)—reported earnings this morning (details are below). So far, earnings season is off to a good start, with the big banks and Netflix (NFLX) beating estimates in recent days.
After reaching new highs this summer, the S&P 500 index has receded to price support around 2,120. That’s frustrating for investors because most good stocks will move somewhat in tandem with the S&P, so your stock portfolios have probably been a disappointment in recent weeks.
I move one stock to Hold this week. And I may make a move or two in the coming days depending on intra-day trading action.
Five Cabot Benjamin Graham Value Investor companies reported quarterly financial results or other noteworthy news. This update also includes three questions from subscribers along with my answers.
The Emerging Markets Timer has shifted to a warning signal, so we are turning more cautious and raising some cash. The markets have taken some of our stocks lower over the past few days, but the portfolio is in pretty good shape overall. Tonight we’re selling MercadoLibre (MELI) and Silicon Motion (SIMO), and putting Baozun (BZUN) and Line Corporation (LN) on Hold.
Yesterday’s sharp selloff turned Cabot’s intermediate-term market timing indicators negative, so it’s time to get a little more conservative.
There are several news items and portfolio highlights in today’s update.
The Dow Jones Industrial Average was unchanged during the past week. The bullish rise in the price of oil to $50 a barrel was offset by worries about the stability of Deutsche Bank in Germany.
In today’s Update, we’ll sell the BulletShares 2016 High Yield Corporate Bond ETF (BSJG), which is maturing at the end of the year, and replace it with the BulletShares 2020 High Yield Corporate Bond ETF (BSJK), which yields significantly more.
Stick with a lean-bullish stance as we wait for the market to show its hand. Our Cabot Trend Lines and Two-Second Indicator are still bullish, but our Cabot Tides remain effectively neutral, and until that changes, stocks and indexes will see lots of choppy action. In the Model Portfolio, we’re sticking with our current 30% in cash and our crop of seven stocks.
Alerts
Altair (ALTR) buys Datawatch (DWCH) and IntriCon (IIN) Reports
Technical indicators say it’s time to trade this gold ETF.

Several readers have asked about what effect tomorrow’s election might have on marijuana stocks, in part because four states have measures on the ballot that would increase legality.
This electrical product maker beat analysts’ estimates by $0.21 last quarter.
This healthcare ETF is also rated ‘Strong Buy’ by Zacks.
I expect a traders’ market through year end. Be wary: just because a stock rebounds nicely this week does not mean that it will maintain those share price gains.
The sell-off in this medical diagnostic company is providing a buying opportunity.
Earnings season has taken its first bite out of one of our holdings.
Next alert downgraded to sell.
This global automaker is seeing a resurgence in its brands, yet the shares trade at a P/E of just 6.

Our portfolio’s earnings season kicked off with a bang last night with three companies opening their books from Q3. As I expected the reactions were significant and unpredictable. We took partial profits on all positions ahead of earnings and have kept them rated hold into the events.
Portfolios
Strategy
A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.
A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.
Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.
Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.
Our Cabot Momentum Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Momentum Trader features.